|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 4.935 USD | +3.89% |
|
-0.90% | -68.68% |
| 12-03 | Orion Lifts FY25 Outlook on Expectation of Milestone Payment for Prostate Cancer Drug | MT |
| 11-19 | Orion S.A. Gains Commercial Traction with Conductive Additives Vital for Grid Modernization | CI |
Main competitors
| Revenues (N-1) | Net Margin (N-1) | EBIT Margin (N-1) | ROE (N-1) | ROA (N-1) | Leverage (N-1) | ||
|---|---|---|---|---|---|---|---|
| 1.88B | 2.35% | 9.42% | 21.56% | 5.57% | 2.85x | ||
| 15.74B | 13.42% | 16.64% | 22.7% | 8.62% | 1.77x | ||
| 8.18B | 14.71% | 18.81% | 25.43% | 9.39% | 2.27x | ||
| 12.98B | 10.61% | 14.57% | 19.26% | 8.04% | 2.22x | ||
| 21.34B | 8.17% | 10.33% | 8% | 6.79% | 1.28x | ||
| 4.53B | -8.93% | 25.2% | -7.51% | -3.49% | -0.87x | ||
| 6.77B | 13.54% | 18.31% | 13.5% | 14.41% | -1.44x | ||
| 2.29B | 22.25% | 26.03% | 25.1% | - | -0.86x | ||
| 5.38B | -24.47% | 10.25% | -2.84% | -1.58% | 2.04x | ||
| 2.5B | -5.74% | 0.02% | -7.8% | -2.98% | 15.67x | ||
| 5.17B | 9.57% | 14.36% | 12.56% | 5.91% | 1.78x | ||
| 3.66B | 6.52% | 8.51% | 5.35% | 2% | - | ||
| 3.1B | 2.63% | 3.17% | 5.2% | 2.08% | 2.42x | ||
| 3.77B | 15.76% | - | - | - | - | ||
| 15.69B | 1.46% | 6.78% | 8.67% | 1.12% | 1.58x | ||
| 9.38B | 9.65% | 13.84% | 16.57% | 6.24% | 2.31x | ||
| 2.46B | 9.94% | 20.14% | 14.92% | 7.14% | 2.74x | ||
| 3.77B | 7.88% | 10.63% | 9.78% | 3.34% | 2.31x | ||
| 4.55B | 3.07% | 5.16% | 5.28% | 1.71% | 5.69x | ||
| Average | 7.01B | 5.91% | 12.9% | 10.87% | 4.37% | 2.57x | |
| Weighted average by Cap. | 10.02B | 8.18% | 14.98% | 14.28% | 6.05% | 2.14x |
- Stock Market
- Equities
- OEC Stock
- Sector Orion S.A.
- Financial comparisons
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition
















